Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocompromised patients:: randomised pilot study (Combistrat Trial)
D O I:
10.1016/S0924-8579(07)70821-X